A randomized comparison of extended-release naltrexone with or without patient navigation vs enhanced treatment-as-usual for incarcerated adults with opioid use disorder
The objective of this study was to conduct a randomized controlled trial to assess the effectiveness of extended-release naltrexone (XR-NTX, Vivitrol ®; Alkermes Inc) alone or in conjunction with patient navigation (XR-NTX + PN) for jail inmates with OUD. We randomized a sample of 135 sentenced jail inmates with moderate to severe OUD to (1) XR-NTX only; (2) XR-NTX + PN; or (3) enhanced treatment-as-usual (ETAU) with drug education, each initiated prior to release from jail.
Source: Journal of Substance Abuse Treatment - Category: Addiction Authors: David Farabee, Timothy Condon, Kevin A. Hallgren, Barbara McCrady Source Type: research
More News: Addiction | Education | Study | Substance Abuse | Substance Abuse Disorders | Universities & Medical Training